ANALYSIS OF HUMAN BRADYKININ RECEPTOR GENE
AND ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE
POLYMORPHISMS IN END-STAGE RENAL DISEASE
AMONG MALAYSIANS
Vasudevan R, Ismail P, Jaafar NI, Mohamad NA, Etemad E, Wan Aliaa WS, Eshkor S
a These authors contributed equally to this article.
*Corresponding Author: Professor Dr. Patimah Ismail, Department of Biomedical Sciences, Faculty of Medical and Health
Science, Universiti Putra Malaysia, Serdang 43400, Selangor DE, Malaysia. Tel.: +60-3-8947-2314. Fax: +60-3-8943-6178.
E-mail: patimashimail@gmail.com and Dr. Ramachandran Vasudevan, Institute of Gerontology, Universiti Putra Malaysia,
Serdang, Selangor DE, 43400, Malaysia. Tel.: +60-3-8947-2752. Fax: +60-3-8947-2738. E-mail: vasuphd@gmail.com.
page: 37
|
|
REFERENCES
1. Eddy AA. Progression in chronic kidney disease.
Adv Chronic Kidney Dis. 2005; 12(4): 353-365.
2. Zolezzi M. Management of dyslipidemia in renal
disease and transplantation. Saudi J Kidney Dis
Transpl. 2006; 17(2): 129-136.
3. Eikmans M, Aben JA, Koop K, Baelde HJ, de
Heer E, Bruijn JA. Genetic factors in progressive
renal disease: the good ones, the bad ones
and the ugly ducklings. Nephrol Dial Transpl.
2006; 21(2): 257-260.
4. Satko SG, Freedman BI, Moossavi S. Genetic
factors in end-stage renal disease. Kidney Int
Suppl. 2005 (94): S46-S49.
5. Braun A, Kammerer S, Bohme E, Muller B,
Roscher AA. Identification of polymorphic sites of
the human bradykinin B2 receptor gene. Biochem
Biophys Res Commun. 1995; 211(1): 234-240.
6. Nagase S, Suzuki H, Wang Y, Kikuchi S, Hirayama
A, Ueda A, et al. Association of eNOS gene
polymorphisms with end stage renal diseases.
Mol Cell Biochem. 2003; 244(1-2): 113-118.
7. Yun Z, Yu-Ping Y, Zong-Wu T, Yang S, Fang Y,
Fang S. Association of endothelial nitric oxide
synthase gene polymorphisms with end-stage
renal disease: a systematic review and metaanalysis.
Ren Fail. 2014; 36(6): 987-993.
8. Zychma MJ, Gumprecht J, Trautsolt W, Szydlowska
I, Grzeszczak W. Polymorphic genes for
kinin receptors, nephropathy and blood pressure
in type 2 diabetic patients. Am J Nephrol. 2003;
23(2): 112-116.
9. Zhou TB, Yin SS. Association of endothelial
nitric oxide synthase Glu298Asp gene polymorphism
with the risk of end-stage renal disease.
Ren Fail. 2013; 35(4): 573-578.
10. Maltais I, Bachvarova M, Maheux P, Perron P,
Marceau F, Bachvarov D. Bradykinin B2 receptor
gene polymorphism is associated with altered
urinary albumin/ creatinine values in diabetic
patients. Can J Physiol Pharmacol. 2002; 80(4):
323-327.
11. Buraczynska M, Ksiazek P, Zaluska W, Nowicka
T, Ksiazek A. Endothelial nitric oxide synthase
gene intron 4 polymorphism in patients with
end-stage renal disease. Nephrol Dial Transpl.
2004; 19(9): 2302-2306.
12. Bachvarov DR, Landry M, Pelletier I, Chevrette
M, Betard C, Houde I, et al. Characterization of
two polymorphic sites in the human kinin B1
receptor gene: altered frequency of an allele in
patients with a history of end-stage renal failure.
J Am Soc Nephrol. 1998; 9(4): 598-604.
13. Tang FY, Liu FY, Xie XW. Association of angiotensin-
converting enzyme and endothelial nitric
oxide synthase gene polymorphisms with vascular
disease in ESRD patients in a Chinese population.
Mol Cell Biochem. 2008;319(1-2):33-9.
14. Li J, Cun Y, Tang WR, Wang Y, Li SN, Ouyang
HR, et al. Association of eNOS gene polymorphisms
with essential hypertension in the Han
population in southwestern China. Genet Molec
Res. 2011; 10(3): 2202-2212.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
